AERIE PHARMACEUTICALS INC Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AERIE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AERIE PHARMACEUTICALS INC for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2021 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 15.66 | 410 | 6,421 | 353,937 | 354.3 K to 353.9 K (-0.12 %) |
| Feb 25 2021 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 15.66 | 763 | 11,949 | 86,709 | 87.5 K to 86.7 K (-0.87 %) |
| Feb 25 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 15.66 | 328 | 5,136 | 264,469 | 264.8 K to 264.5 K (-0.12 %) |
| Feb 25 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 15.66 | 1,700 | 26,622 | 233,396 | 235.1 K to 233.4 K (-0.72 %) |
| Feb 23 2021 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Payment of Exercise | F | 15.95 | 1,542 | 24,595 | 40,437 | 42 K to 40.4 K (-3.67 %) |
| Feb 17 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Option Exercise | M | 0.20 | 60,651 | 11,888 | 0 | |
| Feb 17 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 16.41 | 725 | 11,897 | 264,797 | 265.5 K to 264.8 K (-0.27 %) |
| Feb 17 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Buy | M | 0.20 | 60,651 | 11,888 | 265,522 | 204.9 K to 265.5 K (+29.60 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.72 | 2,500 | 44,300 | 235,096 | 237.6 K to 235.1 K (-1.05 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.68 | 2,496 | 44,129 | 237,596 | 240.1 K to 237.6 K (-1.04 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.68 | 2,958 | 52,297 | 240,092 | 243.1 K to 240.1 K (-1.22 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 17.72 | 666 | 11,802 | 204,871 | 205.5 K to 204.9 K (-0.32 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 17.68 | 701 | 12,394 | 205,537 | 206.2 K to 205.5 K (-0.34 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 17.68 | 876 | 15,488 | 206,238 | 207.1 K to 206.2 K (-0.42 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Payment of Exercise | F | 17.68 | 706 | 12,482 | 41,979 | 42.7 K to 42 K (-1.65 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Payment of Exercise | F | 17.68 | 353 | 6,241 | 42,685 | 43 K to 42.7 K (-0.82 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 17.72 | 1,085 | 19,226 | 87,472 | 88.6 K to 87.5 K (-1.23 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 17.68 | 1,229 | 21,729 | 88,557 | 89.8 K to 88.6 K (-1.37 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 17.68 | 1,438 | 25,424 | 89,786 | 91.2 K to 89.8 K (-1.58 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 17.72 | 921 | 16,320 | 354,347 | 355.3 K to 354.3 K (-0.26 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 17.68 | 1,075 | 19,006 | 355,268 | 356.3 K to 355.3 K (-0.30 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 17.68 | 1,185 | 20,951 | 356,343 | 357.5 K to 356.3 K (-0.33 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | Hollander David | Chief R&D Officer | Option Exercise | A | 17.64 | 50,000 | 882,000 | 50,000 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | Hollander David | Chief R&D Officer | Grant | A | 0.00 | 11,000 | 0 | 33,838 | 22.8 K to 33.8 K (+48.17 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Option Exercise | A | 17.64 | 50,000 | 882,000 | 50,000 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Grant | A | 0.00 | 11,000 | 0 | 207,114 | 196.1 K to 207.1 K (+5.61 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Option Exercise | A | 17.64 | 50,000 | 882,000 | 50,000 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Grant | A | 0.00 | 11,000 | 0 | 43,038 | 32 K to 43 K (+34.33 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Option Exercise | A | 17.64 | 62,500 | 1,102,500 | 62,500 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Grant | A | 0.00 | 14,000 | 0 | 91,224 | 77.2 K to 91.2 K (+18.13 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Option Exercise | A | 17.64 | 52,000 | 917,280 | 52,000 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Grant | A | 0.00 | 12,000 | 0 | 357,528 | 345.5 K to 357.5 K (+3.47 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 17.64 | 125,000 | 2,205,000 | 125,000 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 243,050 | 215.1 K to 243.1 K (+13.02 %) |